Actinium Pharmaceuticals
ATNM
ATNM
44 hedge funds and large institutions have $5.78M invested in Actinium Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.23% more ownership
Funds ownership: 0.25% → 0.48% (+0.23%)
Holders
44
Holding in Top 10
1
Calls
$42K
Puts
–
Top Buyers
| 1 | +$2.05M | |
| 2 | +$1.13M | |
| 3 | +$610K | |
| 4 |
FI
Fosun International
Hong Kong,
China
|
+$133K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$38.1K |
Top Sellers
| 1 | -$377K | |
| 2 | -$68K | |
| 3 | -$28K | |
| 4 |
Bank of New York Mellon
New York
|
-$23K |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$20K |